 | |
- close
- close
|
CANOE.ca
Nov 9
Comment
VANCOUVER, B.C. - Angiotech Pharmaceuticals Inc. (TSX:ANP) is counting on increased sales of its Quill wound closure product line to propel future revenues, predicting it will be No. 2 in its market by the end of 2011.
Canadian Business
Nov 9
Comment
VANCOUVER, B.C. - Angiotech Pharmaceuticals Inc. (TSX:ANP) is counting on increased sales of its Quill wound closure product line to propel future
Oct 20
Comment
On 10/19/09, Angiotech Pharma (NASDAQ:
ANPI
) received notice from the FDA that Bio-Seal is a Class III medical device that requires Pre-Market Approval (PMA) for marketing clearance by the Agency. As a result, ANPI is reviewing its options with...
StreetInsider.com
Oct 19
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Angiotech+Pharmaceuticals+%28ANPI%29+Receives+FDA+Letter+Regarding+510k+Submission+of+Bio-Seal/5027237.html for the full story.
PR Newswire
Oct 9
Comment
Third Quarter 2009 Financial Results VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the third quarter ended September 30, 2009, on
StreetInsider.com
Sep 22
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Angiotech+Pharmaceuticals+%28ANPI%29+Issues+Update+on+TAXUS+Liberte+Stent/4962870.html for the full story.
PR Newswire
Sep 22
Comment
VANCOUVER, Sept. 22 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical
Canadian Business
Sep 2
Comment
VANCOUVER, B.C. - Angiotech Pharmaceuticals Inc. (TSX:ANP) said Wednesday a study found no statistically significant difference between its
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ANPI AT A GLANCE
References
| ||||||
|
|
